ST14 Antikörper (AA 323-372)
-
- Target Alle ST14 Antikörper anzeigen
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
-
Bindungsspezifität
- AA 323-372
-
Reaktivität
- Human, Ratte, Rind (Kuh), Meerschweinchen, Pferd
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ST14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human ST14 / Matriptase
- Homologie
- Percent identity by BLAST analysis: Human, Bovine (100%) Mouse, Rat, Dog, Pig (92%) Horse (85%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa323-372 of human ST14 (Q9Y5Y6, NP_068813). Percent identity by BLAST analysis: Human, Gorilla, Rat, Bovine (100%), Gibbon, Mouse, Elephant, Dog, Bat, Pig, Opossum, Platypus (92%), Drosophila (90%), Horse (85%), Galago (84%), Seabass (83%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product ST14 Primärantikörper
-
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 11-100) antibody
ST14 Reaktivität: Human WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 826-855), (C-Term) antibodyST14 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB2080 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (Internal Region) antibodyST14 Reaktivität: Human, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (C-Term) antibodyST14 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Hund, Schwein, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 Reaktivität: Human, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 298-400) antibodyST14 Reaktivität: Human ELISA Wirt: Maus Monoclonal 2F4 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 10-59) antibodyST14 Reaktivität: Human WB, ELISA, IHC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
- Andere Bezeichnung
- ST14 / Matriptase (ST14 Produkte)
- Hintergrund
-
Name/Gene ID: ST14
Subfamily: Serine S1
Family: Protease
Synonyms: ST14, Epithin, HAI, Prostamin, PRSS14, TADG15, Matriptase, MT-SP1, SNC19, TMPRSS14, MTSP1, Serine protease 14, Serine protease TADG-15, TADG-15 - Gen-ID
- 6768
- NCBI Accession
- NP_068813
- UniProt
- Q9Y5Y6
-
